tiprankstipranks
Trending News
More News >
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
PremiumRatingsPromising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
4M ago
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment
Premium
Company Announcements
CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment
4M ago
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial
Premium
The Fly
CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial
4M ago
CalciMedica name Stephen Bardin as CFO
PremiumThe FlyCalciMedica name Stephen Bardin as CFO
8M ago
CalciMedica price target lowered to $16 from $20 at H.C. Wainwright
Premium
The Fly
CalciMedica price target lowered to $16 from $20 at H.C. Wainwright
8M ago
CalciMedica announces common stock offering, no amount given
Premium
The Fly
CalciMedica announces common stock offering, no amount given
8M ago
CalciMedica reports Q2 EPS (36c), consensus (53c)
PremiumThe FlyCalciMedica reports Q2 EPS (36c), consensus (53c)
11M ago
CalciMedica price target raised to $20 from $14 at Oppenheimer
Premium
The Fly
CalciMedica price target raised to $20 from $14 at Oppenheimer
12M ago
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
Premium
The Fly
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100